Breaking news
its price leaked and there is a good surprise -
between Samsung, LG, TCL, Hisense Philips… find yours -
Potential Realme GT Neo 7 receives certification in China -
you have to self-examine every month! -
The “Sacred Feminine” to fight endometriosis, really? -
Supercomputers: Alps loses its European crown -
Geneva bank Gonet buys ONE swiss bank -

Anticoagulants and anti-inflammatories: a risky duo

Anticoagulants and anti-inflammatories: a risky duo
Anticoagulants and anti-inflammatories: a risky duo

A Danish study confirms that the combination of anticoagulants and non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, significantly increases the risk of internal bleeding, particularly gastrointestinal, cerebral and pulmonary bleeding.

The risk was known, it is now quantified. A study published in theEuropean Heart Journal shows that the simultaneous use of anticoagulants and non-steroidal anti-inflammatory drugs, such as ibuprofen, more than doubles the risk of internal bleeding in patients. This study was conducted by researchers at Aarhus University Hospital, Denmark, on more than 51,000 patients between 2012 and 2022. Therefore, the combination of these two types of drugs is strongly discouraged.

Naproxen tops the list of nonsteroidal anti-inflammatory drugs (NSAIDs) that patients on anticoagulants should be wary of: it increases the risk of internal bleeding by 4.1. It is followed by diclofenac, which increases the risk by 3.3, and ibuprofen, with an increased risk 1.79 times. In general, taking NSAIDs with anticoagulants increases the risk of gastrointestinal bleeding by 2.24, cerebral bleeding by 3.22, and bleeding…

This article is reserved for subscribers. You have 69% left to discover.

Black Friday

-70% on digital subscription

Already subscribed? Log in

Health

-

-

PREV Social networks: how scrolling harms our mental health…
NEXT why should we draw the world’s attention to chronic respiratory diseases?